Study of Antibacterial Prescription Pattern and Adverse Drug Reactions in Childhood Pneumonia

Read full text Summarise with VIRAT
Authors: Brajesh Kumar, Jeetendra Kumar
Cited by: 0
References: 20

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Background: Antibacterial medications are crucial in the treatment of pneumonia, a major cause of death for children worldwide. to ascertain the antibacterials used for pneumonia, including their class, dosage schedule, adverse drug reactions (ADRs), selection criteria, and World Health Organization (WHO) prescription indicators. Methods: From October 2025 to December 2025 this study was conducted among 432 pediatric patients admitted with Pneumonia in JLNMCH, Bhagalpur, and Bihar. Details on antibacterial prescription with selection criteria and associated ADRs were collected. Causality, preventability and severity of ADRs were assessed. WHO prescribing indicators were calculated. Data analysed using SPSS software. Results: Ampicillin (34.6%) with a dosing regimen of 32-66 mg/kg intravenously four times a day (34.4%) and a mean treatment duration of 3.6±1.26 days was the most commonly prescribed antibacterial class, followed by aminopenicillins (61.2%). 57% of patients were administered intravenously, and 99% of patients were treated empirically. Vancomycin-induced Redman Syndrome and gentamicin and ampicillin-induced hypersensitivity reactions were the observed adverse drug events. WHO prescription indicators: 2.42 antibacterials on average per contact, 96.56% of antibacterials administered under generic names, 98.37% of encounters involving injections, and 90.9% of antibacterials from the Essential Medicines List (EML). Conclusion: The most prevalent dose regimen recommended was intravenous ampicillin 32–66 mg/kg four times a day for a mean length of 3.6±1.26 days. Aminopenicillins were the primary antibacterial class. The majority of antibacterials came from EML, were given intravenously, prescribed under generic names, and were chosen experimentally. There were three documented ADRs. Calculations were made for prescribing indicators.

Fields of Study & Subjects

Pneumonia and Respiratory Infections Antibiotic Use and Resistance Antibiotics Pharmacokinetics and Efficacy

Publication details

Journal / source
International Journal of Current Pharmaceutical Review and Research
Volume
18
Issue
02
Publication date
28 February 2026
Language
EN